|
|
||||||||
Department of General Thoracic Surgery, Centre Hospitalier Universitaire Dijon, Hospital du Bocage, Dijon, France
Accepted for publication July 9, 2010.
* Address correspondence to Dr Bernard, Division of Thoracic Surgery, CHU Hospital du Bocage, Blvd de Lattre de Tassigny, Dijon Cedex, 21034, France (Email: alain.bernard{at}chu-dijon.fr).
| Abstract |
|---|
|
|
|---|
Methods: We searched the Medline, Embase, Science Direct, Food and Drug Administration, Cochrane controlled trials register, and clinical trial databases for publications between January 1995 and May 2009 that included terms related to prolonged air leak after lung resection. We included randomized controlled trials comparing glue or patch or buttressed staple line with suture or staple in patients undergoing lung resection (wedge resection or lobectomy). The prespecified primary outcome of our meta-analysis was prolonged air leak more than 7 days. Secondary outcomes were the occurrence of adverse effects.
Results: Thirteen trials were included in the meta-analysis. Overall, the trials had allocated 1,335 patients to glue or patch (1,064 patients) or buttress (271 patients) for the prevention of prolonged air leak after lung resection. The type of buttress used to reinforce the staple line was bovine pericardial strips (271 patients). In the control group of all trials for air-leakage management, single or continuous running sutures or staples were used according to the routine of the center. The use of glue or a patch or buttressing compared with control groups (1,335 patients) decreased prolonged air leak more than 7 days. Indeed, the pooled effect size odds ratio was 0.55 (95% confidence interval: 0.386 to 0.79). An I2 of 0% indicated low between-trial heterogeneity. The funnel-plot asymmetry coefficient was significantly different from zero (asymmetry coefficient –1.23 (95% confidence interval: –2.38 to –0.086; p < 0.04), indicating the presence of publication bias. Neither glue nor a patch nor buttressing influenced the occurrence of postoperative complications such as atelectasis, hemothorax, pneumonia, pneumothorax, and mortality. Eight trials (1,020 patients) showed that, compared with control groups, the use of glue or a patch or buttressing decreased postoperative arrhythmia, which yielded a pooled odds ratio of 0.44 (95% confidence interval: 0.275 to 0.72).
Conclusions: The use of surgical sealants and buttressing decreased the risk of prolonged air leakage and postoperative arrhythmia after pulmonary resection. However, given the possibility of publication bias, the conclusions should be interpreted with caution.
| Introduction |
|---|
|
|
|---|
Various additional techniques, including the use of a variety of sealants, such as fibrin glue, synthetic materials, and collagen patches coated with fibrinogen and thrombin, have been employed to minimize the intensity and duration of air leaks. Other techniques using staples and strips of reinforcing material to buttress the staple lines have also been tried to reduce air leaks after lung resection.
Several trials have compared these different techniques to reduce air leakage with classical methods. We performed a systematic and meta-analysis of randomized controlled trials that compared the use of surgical sealants or buttressed staple lines with the use standard methods. The aim of our meta-analysis was to determine the effectiveness and safety of different techniques to reduce the percentage of patients with a prolonged air leak after pulmonary resection.
| Material and Methods |
|---|
|
|
|---|
Trial Selection
We included randomized controlled trials comparing glue or patch or buttressed staple line with suture or staple in patients undergoing a lung resection (wedge resection or lobectomy). We included every randomized controlled trial that reported on the primary or secondary outcome of prolonged air leak for more than 7 days. Two reviewers (G.M. and H.A.) independently evaluated the reports for their eligibility. Disagreements were resolved by consensus.
Quality Assessment
Two reviewers (G.M. and H.A.) independently assessed concealment of treatment allocation, blinding (masking) and analyses. Concealment of allocation was considered adequate if the investigators responsible for patient selection were unable to determine before allocation which treatment was next in line (central randomization, sealed, opaque, sequentially numbered assignment envelopes). Patient blinding was considered adequate if it was stated that patients were blind to the assigned treatment. Therapist blinding was considered adequate if participants assessing the outcomes were blinded to group assignment. The number of patients randomized per group and the number of patients analyzed per group were extracted to distinguish between trials that had included all randomized patients in the analysis (considered as an intent-to-treat analysis and therefore adequate) and trials that had not. Disagreements were resolved by consensus.
Outcome measures
The prespecified primary outcome of our meta-analysis was prolonged air leak longer than 7 days. Secondary outcomes were the occurrence of adverse effects.
Data collection
Data on publication status, trial design, patient characteristics (age, pulmonary pathology, type of procedure) treatment regimens, prolonged air leak more than 7 days, adverse effects, quality assessment and funding were extracted in duplicate (by G.M. and H.A.) using a standardized form. Any disagreements were resolved by discussion.
Statistical Analysis
For prolonged air leak more than 7 days considered as dichotomous outcomes, effect sizes were estimated by odds ratio (OR). An effect size less than 1 indicates the superiority of sealant treatment compared with suture or staple. We used a random-effects meta-analysis to pool effect sizes and calculated the I2 statistic for each meta-analysis. This statistic describes the percentage of total variation across a trial that is attributable to statistical heterogeneity rather than chance [3]. The I2 values of 25%, 50%, and 75% correspond to low, moderate, and high between-trial heterogeneity, respectively. We performed stratified meta-analyses to investigate potential sources of statistical heterogeneity. The following trial characteristics were considered for stratification: adequacy of concealment of allocation, blinding of patients, adequacy of the analysis, trial size, type of pathology, type of procedure, and type of sealant. We used prespecified cutoffs of 100 randomized patients to distinguish between small- and large-scale trials. Univariable random-effects meta-regression analysis was used to examine whether effect sizes were affected by these factors.
We performed post hoc sensitivity analyses excluding outlier studies from the main meta-analysis. Studies were considered outliers if the confidence interval of the estimated effect size from these studies did not overlap with pooled overall effect size. Sensitivity analyses also focused on the buttressed staple line and surgery for emphysema when studies were excluded from the main meta-analysis.
Asymmetry of the funnel-plot was assessed by the asymmetry coefficient to search for likely effects of publication bias [4]. The Egger test detects funnel plot asymmetry by determining whether the intercept deviates significantly from zero in a regression of standardized effect estimates against their precision [4].
For these trials, we determined the contribution to Cochran's heterogeneity Q statistic in the overall analysis [5]. An approach developed by the DerSimonian and Laird methods was used to perform random-effects meta-analysis for overall effect measures [6]. All confidence intervals (CI) relate to the 95% limit, and p values were two-sided. Analyses were performed using STATA 11 statistical software (StataCorp, College Station, TX).
In addition, we conducted a Bayesian approach to random-effects meta-analysis [7]. We performed a sensitivity analysis to prior distributions. The three Bayesian models differ only with respect to the prior placed on the between-study variance
2: (1) a noninformative inverse gamma (IG [0.0001, 0.0001]); (2) a half-normal (0, 1,000); and (3) a Dumouchel prior [8]. Bayesian analysis was performed using WinBugs software [9].
| Results |
|---|
|
|
|---|
|
|
Pooled Effect Sizes
A total of 13 trials contributed to the meta-analysis of the prevention of prolonged air leak more than 7 days. The glue or patch or buttress compared with control groups (1,335 patients) decreased prolonged air leak of more than 7 days. Indeed, the pooled effect size was 0.55 (95% CI: 0.386 to 0.79; Fig 2). An I2 of 0% indicated low between-trial heterogeneity (p < 0.5 for heterogeneity). The results from stratified analyses are presented in Table 2. Concealment of allocation, blinding, intent-to-treat, trial size, emphysema, procedure, and type of sealant had no influence on between-trial heterogeneity and p values for interactions between trial characteristics (Table 2).
|
|
Bayesian approaches with a sensitivity analysis to prior distributions demonstrated that glue, sealant, patch, or buttress decreased prolonged air leak of more than 7 days compared with control groups (Table 3). The effect size was comparable to that estimated by the frequentist method.
|
|
|
| Comment |
|---|
|
|
|---|
Presumably, a publication bias was identified as shown in the funnel plot (Fig 3). The distribution of studies is asymmetrical around zero because smaller studies, which showed no statistically significant effects, remain unpublished [24]. Small studies are often more significant than studies involving larger cohorts. Because of the risk of publication bias, the findings of our meta-analysis must be interpreted with caution.
Our meta-analysis did not reveal heterogeneity between studies for this endpoint. All authors had probably applied the same definition for this endpoint, thus reinforcing its clinical relevance. However, the quality of the studies included in this meta-analysis is intermediate. Indeed, for six of the 13 trials [10, 12, 13, 15, 17, 18], no information on the randomization method was provided. These studies generate a potential selection bias. In only five of the 13 studies [13, 14, 16, 21, 22] were outcomes evaluated without knowledge of the assigned treatment. However, it is unlikely that there is a measurement bias. Indeed, patients with a prolonged air leak for more than 7 days are obliged to keep their chest tube. Consequently, this outcome is objective enough to prevent a systematic error in measurement. The homogeneity between studies argues in favor of this hypothesis. The sensitivity analysis excluding trials with a buttressed staple line, and the surgical treatment of emphysema did not change the pooled effect of the meta-analysis.
For most adverse events, no excess risk was reported. Surprisingly, the surgical sealants and buttress significantly reduced the occurrence of postoperative arrhythmia. The prevalence of arrhythmia after lung surgery [25] is between 8% and 42%. Factors influencing postoperative arrhythmia were age, a history of cardiac disease and the type of pulmonary resection including pneumonectomy [25]. In a randomized controlled trial, these factors are distributed equally in each group and are therefore unlikely to influence the occurrence of arrhythmia. The only factor that may differ in the two treatment groups is a persistent chest tube in patients with prolonged air leak. The chest tube could favor the occurrence of arrhythmia.
The effect size of the four methods is in the same direction, as indicated by the absence of significant interaction. This "naive" indirect comparison does not show whether one method is superior to the others in its ability to reduce prolonged air leak after lung resection. The systematic search of the literature did not identify trials that made a direct comparison between different products. To answer this question, indirect comparisons may help to classify these different methods, depending on the effect sizes. The use of a surgical sealant to prevent prolonged air leak increases costs. But only medicoeconomic studies may show that the cost of these methods are offset by the reduction in the length of hospital stay [26].
In conclusion, this meta-analysis showed that the use of glues, patches, or buttressing reduces the occurrence of prolonged air leak after pulmonary resection. However, publication bias should temper the conclusions of this meta-analysis. Further trials will confirm the effectiveness of these methods on the prevention of postoperative prolonged air leak.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
S. Liang, J. Ivanovic, S. Gilbert, D. E. Maziak, F. M. Shamji, R. S. Sundaresan, and A. J. E. Seely Quantifying the incidence and impact of postoperative prolonged alveolar air leak after pulmonary resection J. Thorac. Cardiovasc. Surg., April 1, 2013; 145(4): 948 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Schuchert, G. Abbas, J. P. Landreneau, J. D. Luketich, and R. J. Landreneau Use of energy-based coagulative fusion technology and lung sealants during anatomic lung resection J. Thorac. Cardiovasc. Surg., September 1, 2012; 144(3): S48 - S51. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Pedersen, J. L. Honge, H. K. Pilegaard, and J. M. Hasenkam Comparative Study of Lung Sealants in a Porcine Ex Vivo Model Ann. Thorac. Surg., July 1, 2012; 94(1): 234 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cardillo, F. Carleo, L. Carbone, A. R. De Massimi, A. Lococo, P. F. Santini, A. Janni, and A. Gonfiotti Adverse effects of fibrin sealants in thoracic surgery: the safety of a new fibrin sealant: multicentre, randomized, controlled, clinical trial Eur J Cardiothorac Surg, March 1, 2012; 41(3): 657 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gonfiotti, P. F. Santini, M. Jaus, A. Janni, A. Lococo, A. R. De Massimi, A. D'Agostino, F. Carleo, M. Di Martino, V. Larocca, et al. Safety and Effectiveness of a New Fibrin Pleural Air Leak Sealant: A Multicenter, Controlled, Prospective, Parallel-Group, Randomized Clinical Trial Ann. Thorac. Surg., October 1, 2011; 92(4): 1217 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Shrager Invited Commentary Ann. Thorac. Surg., December 1, 2010; 90(6): 1785 - 1785. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |